Skip to main navigation Skip to search Skip to main content

Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea

  • Jae J. Kim
  • , Rita Reddy
  • , Miae Lee
  • , Jong G. Kim
  • , Fouad A.K. El-Zaatari
  • , Michael S. Osato
  • , David Y. Graham
  • , Dong H. Kwon

Research output: Contribution to journalArticlepeer-review

135 Scopus citations

Abstract

Antibiotic resistance in Helicobacter pylori varies according to geographical region. We studied the primary resistance rates among 652 H. pylori isolated from Korea in relation to collection date, disease presentation, age and gender. Resistance rates were 40.6% (metronidazole), 5.9% (clarithromycin), 5.3% (tetracycline), 0% (amoxycillin), 1.5% (furazolidone) and 1.5% (nitrofurantoin). Resistance to metronidazole and clarithromycin increased from 1994 to 1999 (from 33.3 to 47.7% and 4.8 to 7.7%, respectively), but the differences only reached significance when rates of metronidazole resistance in women were compared with those in men (48.6 versus 36.9%).

Original languageEnglish
Pages (from-to)459-461
Number of pages3
JournalJournal of Antimicrobial Chemotherapy
Volume47
Issue number4
DOIs
StatePublished - 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea'. Together they form a unique fingerprint.

Cite this